Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Sheridan PubFactory full text link Sheridan PubFactory Free PMC article
Full text links

Actions

Share

Review
.2019 Dec 1;69(6):520-534.
doi: 10.30802/AALAS-CM-19-000041. Epub 2019 Dec 20.

A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies

Affiliations
Review

A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies

George J DeMarco et al. Comp Med..

Abstract

One of the most significant challenges facing investigators, laboratory animal veterinarians, and IACUCs, is how to balance appropriate analgesic use, animal welfare, and analgesic impact on experimental results. This is particularly true for in vivo studies on immune system function and inflammatory disease. Often times the effects of analgesic drugs on a particular immune function or model are incomplete or don't exist. Further complicating the picture is evidence of the very tight integration and bidirectional functionality between the immune system and branches of the nervous system involved in nociception and pain. These relationships have advanced the concept of understanding pain as a protective neuroimmune function and recognizing pathologic pain as a neuroimmune disease. This review strives to summarize extant literature on the effects of pain and analgesia on immune system function and inflammation in the context of preclinical in vivo studies. The authors hope this work will help to guide selection of analgesics for preclinical studies of inflammatory disease and immune system function.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Interactions between nociceptive neurons and microglial cells after neuronal damage or activation by alarmins are depicted. l-glutamate (l-glu), substance P (SubP), adenosine triphosphate (ATP), brain-derived neurotrophic factor (BDNF), cysteine-cysteine chemokine ligand CCL2 neurokinin-1 receptors (NK-1R), extracellular signal-regulated kinase (ERK), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPAR), cyclic adenosine monophosphate response element binding protein (CREB). ATP purinergic receptors, (P2X7, P2Y12 and P2Y13R), mitogen-activated kinase (p38), c-jun-N terminal kinase (JNK), nuclear factor kappa B (NFκB), Interleukin-1β (IL1β) and its receptor, (IL-1R) tumor necrosis factor α (TNFα) and its receptor (TNFR), chloride (Cl−) transporter (KCC2), gamma aminobutyric acid A receptor (GABAA), chemokine ligand 2 (CCL2), chemokine receptor 2,3 (CCR2, CCR3), Cathepsin S (CatS), fractalkine (FKN, also termed CX3C-chemokine ligand 1), chemokine receptor 1 (CX3CR), Matrix metalloprotease 2, 9 (MMP2 MMP9), toll-like receptor 4 (TLR4).Reprinted by permission from Wolters Kluwer Health. Central neuron-glia interactions and neuropathic pain, Eduardo E. Benarroch 2010
Figure 2.
Figure 2.
Summary of vaccine and antibody production models in which analgesic effects were evaluated. HI – humeral immunity, CMI – cell mediated immunity, SID – once a day, BID – twice a day, PO – by mouth, SC – subcutaneous, IP - intraperitoneal
Figure 3.
Figure 3.
Summary of inflammation models in which analgesic effects were evaluated. IT – intrathecal, SID – once a day, BID – twice a day, PO – by mouth, SC – subcutaneous, IP - intraperitoneal
Figure 4.
Figure 4.
Summary of IBD models in which analgesic effects were evaluated. SID – once a day, BID – twice a day, PO – by mouth, SC – subcutaneous, IP - intraperitoneal
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, Mackie K, Marian C, Batkai S, Parolaro D, Fischer MJ, Reeh P, Kunos G, Kress M, Lutz B, Woolf CJ, Kuner R. 2007. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10:870–879. 10.1038/nn1916. - DOI - PMC - PubMed
    1. Agha AM, El-Khatib AS, Al-Zuhair H. 1999. Modulation of oxidant status by meloxicam in experimentally induced arthritis. Pharmacol Res 40:385–392. 10.1006/phrs.1999.0522. - DOI - PubMed
    1. Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Höhne C, Fritz G, Keh D. 2008. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth 101:781–787. 10.1093/bja/aen287. - DOI - PubMed
    1. Ahn K, McKinney MK, Cravatt BF. 2008. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108:1687–1707. 10.1021/cr0782067. - DOI - PMC - PubMed
    1. Al-Hashimi M, Scott SWM, Thompson JP, Lambert DG. 2013. Opioids and immune modulation: more questions than answers. Br J Anaesth 111:80–88. 10.1093/bja/aet153. - DOI - PubMed

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full text links
Sheridan PubFactory full text link Sheridan PubFactory Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp